DCIS Precision
  • Consortium
  • General Public
  • Scientific Community
  • Publications
  • Home
  • News
  • Contact
  • Clinical Trials
  • |
  • NL
Select Page
PRECISION publishes its second newsletter

PRECISION publishes its second newsletter

by MSdcisPrecision345af2af1 | Aug 14, 2020 | News

Read the newsletter by clicking on the link below https://www.dcisprecision.org/wp-content/uploads/2020/08/DCIS-Nieuwsbrief-Final_140820.pdf
Preventing unnecessary breast cancer treatment

Preventing unnecessary breast cancer treatment

by MSdcisPrecision345af2af1 | May 24, 2017 | News, Uncategorized

Every year, around 6,300 women in the UK are told they have a condition called ductal carcinoma in situ (DCIS). In the US this figure sits at over 50,000 women, while in the Netherlands 2,500 women are given this diagnosis. These women are often told the condition is...
PRECISION kick off meeting in Amsterdam

PRECISION kick off meeting in Amsterdam

by MSdcisPrecision345af2af1 | May 18, 2017 | News

Steering group, collaborators and all patient advocates came together to celebrate the start of PRECISION. Research plans were discussed as well as the collaboration in more detail.
Patholoog Jelle Wesseling over borstkankeronderzoek @Pauw – VARA

Patholoog Jelle Wesseling over borstkankeronderzoek @Pauw – VARA

by MSdcisPrecision345af2af1 | May 16, 2017 | News, Uncategorized

Patholoog Jelle Wesseling van het Antonie van Leeuwenhoek-ziekenhuis geeft woensdag 17 mei het startsein voor ‘De Marathon tegen Kanker’ waarin vele Bekende en onbekende Nederlanders zich weer gaan inzetten om zoveel mogelijk geld op te halen voor KWF. En dat is niet...

Is Stage Zero breast cancer really cancer? 7 ON YOUR SIDE investigates the controversy

by MSdcisPrecision345af2af1 | May 16, 2017 | News

The word cancer strikes fear into Americans with good reason. Last year, nearly 1.7 million people in the US were diagnosed with it. But there is an increasingly loud conversation among some doctors and patients questioning certain diagnoses and the aggressive...
« Older Entries
Next Entries »

More News

  • Low-Risk DCIS Research Update and Resources by PRECISION Patient Advocates
  • Challenging the current dogma: DCIS – a precursor lesion, a risk lesion or both for subsequent invasive breast cancer?
  • PRECISION researcher wins prestigious Veni Grant awarded by the Dutch Research Council (NWO)
  • Can invasive treatment be avoided for patients diagnosed with DCIS?
  • PRECISION launches a Series of Plain Language Summaries
  • PRECISION publishes its second newsletter
  • 5th World Congress on Controversies in Breast Cancer (CoBrCa 2019, San Francisco)
  • 2nd PRECISION Annual Meeting 13-14 June 2019
  • Feiten en Vragen LORD studie
  • PRECISION publishes it’s first newsletter
  • PRECISION publishes review article – Ductal carcinoma in situ: to treat or not to treat, that is the question
  • Becoming Professor…
  • ‘Over-diagnosis and over-treatment of breast cancer is a travesty in women’s healthcare’
  • PRECISION @ Association of Breast Surgery Conference 2019 – Future Management of DCIS
  • DCIS Dilemmas – clinician and patient advocate interactive session 13th June, NKI, Amsterdam
©2023 DCISprecision.org | Design by Mediaschip | FAQ | Cookie Policy